[The ODYSSEY OUTCOMES trial]

G Ital Cardiol (Rome). 2019 Apr;20(4):187-189. doi: 10.1714/3126.31069.

[Article in Italian]

Authors

Lucia Coppini¹, Giuseppe Musumeci¹

Affiliation

¹ U.S.C. Cardiologia, Ospedale Santa Croce e Carle, Cuneo.

PMID: 30920543
DOI: 10.1714/3126.31069

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Antibodies, Monoclonal, Humanized / adverse effects
Cardiovascular Diseases / etiology
Cardiovascular Diseases / prevention & control*
Humans
Hypercholesterolemia / complications
Hypercholesterolemia / drug therapy*
Randomized Controlled Trials as Topic
Risk Factors

Substances

Antibodies, Monoclonal, Humanized
alirocumab